Johnson & Johnson’s medical device and diagnostics business witnessed a 13% increase in revenue in the first quarter of 2010 after being boosted by sales of surgical care products and orthopaedic devices. J&J’s medtech revenue was $6.23bn for the period, up from ...
Please Login to read the full article.
